Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 3Skin Neoplasms 2Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Skin Diseases 1Rectal Neoplasms 1Rectal Diseases 1Neoplasm Metastasis 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1Digestive System Diseases 1Colonic Diseases 1Biliary Tract Neoplasms 1

Interventions

Bevacizumab 5Leucovorin 4Irinotecan 4Fluorouracil 4Oxaliplatin 3Capecitabine 3Drug Therapy 2trifluridine tipiracil drug combination 1romiplostim 1napabucasin 1entecavir 1encorafenib 1durvalumab 1apatinib 1abelacimab 1Sunitinib 1Specimen Handling 1Sodium Chloride 1S-1 plus cisplatin 1Radiosurgery 1Palonosetron 1Oviposition 1Nutrition Assessment 1Nucleotides 1Methylphenidate 1Memantine 1Melatonin 1Magnetic Resonance Spectroscopy 1MAA868 1Levoleucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Gastrointestinal Neoplasms × encorafenib × Clear all
NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡